The limitations of safety testing.
D000818:Animals; D001847:Bone Diseases / Q000453:epidemiology; D002273:Carcinogens; D003550:Cystic Fibrosis / Q000453:epidemiology; D005223:Fats; D005465:Fluorocarbon Polymers; D006168:Guinea Pigs; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008103:Liver Cirrhosis / Q000453:epidemiology; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009821:Oils; D010529:Peritoneal Cavity; D010534:Peritoneal Neoplasms / Q000139:chemically induced; D014677:Pharmaceutical Vehicles; D051381:Rats; D014304:Triolein; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology
D002273:Carcinogens; D005223:Fats; D005465:Fluorocarbon Polymers; D009821:Oils; D014677:Pharmaceutical Vehicles; D014304:Triolein